Targeting prostate cancer cells with hybrid elastin-like polypeptide/liposome nanoparticles

References

• Australian Institute of Health and Welfare (AIHW) 2017Australian Cancer Incidence and Mortality (ACIM) booksCanberraAIHW Available from: http://www.aihw.gov.au//reports/cancer/acim-books>Accessed June 15, 2017
   Google Scholar
• SeidenfeldJSamsonDJHasselbladVSingle-therapy androgen suppression in men with advanced prostate cancer: a systematic review and meta-analysisAnn Intern Med2000132756657710744594
   PubMed Web of Science ®Google Scholar
• SuzukiHOkiharaKMiyakeHNonsteroidal Antiandrogen Sequential Alternation for Prostate Cancer Study GroupAlternative nonsteroidal antiandrogen therapy for advanced prostate cancer that relapsed after initial maximum androgen blockadeJ Urol2008180392192718635218
   PubMed Web of Science ®Google Scholar
• SternbergCNWhelanPHetheringtonJGenitourinary Tract Group of the EORTCPhase III trial of satraplatin, an oral platinum plus prednisone vs. prednisone alone in patients with hormone-refractory prostate cancerOncology20056812915741753
   PubMed Web of Science ®Google Scholar
• KantoffPWHalabiSConawayMHydrocortisone with or without mitoxantrone in men with hormone-refractory prostate cancer: results of the cancer and leukemia group B 9182 studyJ Clin Oncol19991782506250610561316
   PubMed Web of Science ®Google Scholar
• StorlieJABucknerJCWisemanGABurchPAHartmannLCRichardsonRLProstate specific antigen levels and clinical response to low dose dexamethasone for hormone-refractory metastatic prostate carcinomaCancer1995761961008630883
   PubMed Web of Science ®Google Scholar
• NishimuraKNonomuraNYasunagaYLow doses of oral dexamethasone for hormone-refractory prostate carcinomaCancer200089122570257611135218
   PubMed Web of Science ®Google Scholar
• SaikaTKusakaNTsushimaTOkayama Urological Cancer Collaborating GroupTreatment of androgen-independent prostate cancer with dexamethasone: A prospective study in stage D2 patientsInt J Urol20018629029411389744
   PubMed Web of Science ®Google Scholar
• SmallEJBaronABokRSimultaneous antiandrogen withdrawal and treatment with ketoconazole and hydrocortisone in patients with advanced prostate carcinomaCancer1997809175517599351544
   PubMed Web of Science ®Google Scholar
• KeizmanDHuangPCarducciMAEisenbergerMAContemporary experience with ketoconazole in patients with metastatic castration-resistant prostate cancer: clinical factors associated with PSA response and disease progressionProstate201272446146721688281
   PubMed Web of Science ®Google Scholar
• ReidAHAttardGDanilaDCSignificant and sustained antitumor activity in post-docetaxel, castration-resistant prostate cancer with the CYP17 inhibitor abiraterone acetateJ Clin Oncol20102891489149520159823
   PubMed Web of Science ®Google Scholar
• DanilaDCMorrisMJde BonoJSPhase II multicenter study of abiraterone acetate plus prednisone therapy in patients with docetaxel-treated castration-resistant prostate cancerJ Clin Oncol20102891496150120159814
   PubMed Web of Science ®Google Scholar
• O’Hanlon BrownCWaxmanJCurrent management of prostate cancer: dilemmas and trialsBr J Radiol201285Spec No 1S28S4023118100
   PubMedGoogle Scholar
• YagodaAPetrylakDCytotoxic chemotherapy for advanced hormone-resistant prostate cancerCancer1993713 Suppl 1109811097679039
   PubMed Web of Science ®Google Scholar
• HuwylerJDreweJKrähenbühlSTumor targeting using liposomal antineoplastic drugsInt J Nanomedicine200831212918488413
   PubMed Web of Science ®Google Scholar
• DreherMRRaucherDBaluNMichael ColvinOLudemanSMChilkotiAEvaluation of an elastin-like polypeptide–doxorubicin conjugate for cancer therapyJ Control Release2003911–2314312932635
   PubMed Web of Science ®Google Scholar
• FurgesonDYDreherMRChilkotiAStructural optimization of a “smart” doxorubicin-polypeptide conjugate for thermally targeted delivery to solid tumorsJ Control Release2006110236236916303202
   PubMed Web of Science ®Google Scholar
• ShiPAluriSLinYAElastin-based protein polymer nanoparticles carrying drug at both corona and core suppress tumor growth in vivoJ Control Release2013171333033823714121
   PubMed Web of Science ®Google Scholar
• KimMSLeeDWParkKTemperature-triggered tumor-specific delivery of anticancer agents by cRGD-conjugated thermosensitive liposomesColloids Surf B Biointerfaces2014116172524441178
   PubMed Web of Science ®Google Scholar
• LeeHKimHRLarsonRGParkJCEffects of the size, shape, and structural transition of thermosensitive polypeptides on the stability of lipid bilayers and liposomesMacromolecules2012451773047312
   Web of Science ®Google Scholar
• LeeHKimHRParkJCDynamics and stability of lipid bilayers modulated by thermosensitive polypeptides, cholesterols, and PEGylated lipidsPhys Chem Chem Phys20141683763377024429702
   PubMed Web of Science ®Google Scholar
• NaKLeeSAJungSHHyunJShinBCElastin-like polypeptide modified liposomes for enhancing cellular uptake into tumor cellsColloids Surf B Biointerfaces20129113013622104404
   PubMed Web of Science ®Google Scholar
• ParkSMChaJMNamJFormulation optimization and in vivo proof-of-concept study of thermosensitive liposomes balanced by phospholipid, elastin-like polypeptide, and cholesterolPLoS One201497e10311625068721
   PubMed Web of Science ®Google Scholar
• ParkSMKimMSParkSJNovel temperature-triggered liposome with high stability: formulation, in vitro evaluation, and in vivo study combined with high-intensity focused ultrasound (HIFU)J Control Release2013170337337923770213
   PubMed Web of Science ®Google Scholar
• ZhangWGargSEldiPTargeting prostate cancer cells with genetically engineered polypeptide-based micelles displaying gastrin-releasing peptideInt J Pharm2016513127027927633281
   PubMedGoogle Scholar
• DuaJSRanaACBhandariAKLiposome: methods of preparation and applicationsInt J Pharm Stud Res201231420
   Google Scholar
• DingTXueYLuHHuangZSunJEffect of particle size of hydroxyapatite nanoparticles on its biocompatibilityIEEE Trans Nanobioscience201211433634022438516
   PubMed Web of Science ®Google Scholar
• KalepuSKumarTSBethaSMohanMLiposomal drug delivery system – a comprehensive reviewInt J Drug Dev Res2013546275
   Google Scholar
• YangZZLiJQWangZZDongDWQiXRTumor-targeting dual peptides-modified cationic liposomes for delivery of siRNA and docetaxel to gliomasBiomaterials201435195226523924695093
   PubMed Web of Science ®Google Scholar
• LiuZLiuDWangLZhangJZhangNDocetaxel-loaded pluronic p123 polymeric micelles: in vitro and in vivo evaluationInt J Mol Sci20111231684169621673916
   PubMed Web of Science ®Google Scholar
• SannaVRoggioAMPosadinoAMNovel docetaxel-loaded nanoparticles based on poly(lactide-co-caprolactone) and poly(lactide-co-glycolide-co-caprolactone) for prostate cancer treatment: formulation, characterization, and cytotoxicity studiesNanoscale Res Lett20116126026821711774
   PubMed Web of Science ®Google Scholar
• YeboahACohenRIRabolliCYarmushMLBerthiaumeFElastin-like polypeptides: a strategic fusion partner for biologicsBiotechnol Bioeng201611381617162727111242
   PubMed Web of Science ®Google Scholar
• MeyerDEChilkotiAProtein purification by inverse transition cyclingGolemisEAAdamsPDProtein-Protein Interactions: A Molecular Cloning ManualCold Spring Harbor, N.YCold Spring Harbor Laboratory Press2002 Chapter 18329343
   Google Scholar
• ImmordinoMLBrusaPArpiccoSStellaBDosioFCattelLPreparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing docetaxelJ Control Release200391341742912932719
   PubMed Web of Science ®Google Scholar
• PereiraSEgbuRJannatiGAl-JamalWTDocetaxel-loaded liposomes: The effect of lipid composition and purification on drug encapsulation and in vitro toxicityInt J Pharm2016514115015927863659
   PubMed Web of Science ®Google Scholar
• NaguibYWRodriguezBLLiXHurstingSDWilliamsRO3rdCuiZSolid lipid nanoparticle formulations of docetaxel prepared with high melting point triglycerides: in vitro and in vivo evaluationMol Pharm20141141239124924621456
   PubMed Web of Science ®Google Scholar
• RaviSKrishnamurthyVRCavesJMHallerCAChaikofELMaleimide-thiol coupling of a bioactive peptide to an elastin-like protein polymerActa Biomater20128262763522061108
   PubMed Web of Science ®Google Scholar
• CassinelloJCarballido RodriguezJAnton AparicioLRole of taxanes in advanced prostate cancerClin Transl Oncol2016181097298026856599
   PubMed Web of Science ®Google Scholar
• RaffySTeissiéJControl of lipid membrane stability by cholesterol contentBiophys J19997642072208010096902
   PubMed Web of Science ®Google Scholar
• SoemaPCWillemsGJJiskootWAmorijJPKerstenGFPredicting the influence of liposomal lipid composition on liposome size, zeta potential and liposome-induced dendritic cell maturation using a design of experiments approachEur J Pharm Biopharm20159442743526144666
   PubMed Web of Science ®Google Scholar
• ZhangJAAnyarambhatlaGMaLDevelopment and characterization of a novel Cremophor EL free liposome-based paclitaxel (LEP-ETU) formulationEur J Pharm Biopharm200559117718715567316
   PubMed Web of Science ®Google Scholar
• LiuDZTsengLPLiangHJChungTWHuangYYLiposomes incorporated with cholesterol for drug release triggered by magnetic fieldJ Med Biol Eng2007272934
   Google Scholar
• FunakoshiYIwaoYNoguchiSItaiSEffect of alkyl chain length and unsaturation of the phospholipid on the physicochemical properties of lipid nanoparticlesChem Pharm Bull (Tokyo)201563973173626329867
   PubMed Web of Science ®Google Scholar
• NaikSPatelDSurtiNMisraAPreparation of PEGylated liposomes of docetaxel using supercritical fluid technologyJ Supercritical Fluids2010541110119
   Web of Science ®Google Scholar
• ErnstingMJMurakamiMRoyALiSDFactors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticlesJ Control Release2013172378279424075927
   PubMed Web of Science ®Google Scholar
• ShahMHsuehPYSunGChangHYJanibSMMacKayJABiodegradation of elastin-like polypeptide nanoparticlesProtein Sci201221674375022434766
   PubMed Web of Science ®Google Scholar
• SzokaFJrPapahadjopoulosDComparative properties and methods of preparation of lipid vesicles (liposomes)Ann Rev Biophys Bioeng198094675086994593
   PubMedGoogle Scholar